Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
INM-755 (Cannabinol) Cream for Treatment of Epidermolysis BullosaNCT04908215INMPhase 2Completed2023-04-03Actual
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque PsoriasisNCT04908514ALDXPhase 2Completed2022-01-21Actual
An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEENCT04912856XENEPhase 3Terminated2023-11-17Actual
Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.NCT04913675VIRPhase 3Terminated2022-07-19Actual
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis BullosaNCT04917874KRYSPhase 3Completed2023-07-31Actual
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLCNCT04919811NUVBPhase 2Active not recruiting2025-06-11Actual
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.NCT04925024LGVNPhase 2Active not recruiting2026-06-30Estimated
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224NCT04932512IONSPhase 2Completed2024-01-10Actual
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat StudiesNCT04933721BioCryst PharmaceuticalsPhase 3Enrolling by invitation2031-08Estimated
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)NCT04944784CytokineticsPhase 3Terminated2023-07-18Actual
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease AgitationNCT04947553AXSMPhase 3Completed2024-12-03Actual
Study of INBRX-109 in Conventional ChondrosarcomaNCT04950075INBXPhase 2Active not recruiting2025-09-30Actual
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)NCT04951219MDGLPhase 3Active not recruiting2027-03Estimated
Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSNCT04957485SIGA TechnologiesPhase 2Active not recruiting2027-01-01Estimated
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) PathwayNCT04963231RYTMPhase 2Completed2023-08-04Actual
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)NCT04964089KODPhase 3Completed2023-03-28Actual
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of ObesityNCT04966741RYTMPhase 3Completed2023-09-18Actual
A Clinical Trial to Assess Subjects With Dry Eye Disease.NCT04971031ALDXPhase 2Completed2021-09-08Actual
Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 DaysNCT04971109SIGA TechnologiesPhase 3Completed2023-05-12Actual
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)NCT04973228ARQTPhase 3Completed2022-04-06Actual
Afrezza® INHALE-1 Study in PediatricsNCT04974528Mannkind CorporationPhase 3Completed2024-10-03Actual
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B InfectionNCT04980482Arbutus Biopharma CorporationPhase 2Completed2025-03-13Actual
Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisNCT04984278Jazz PharmaceuticalsPhase 3Terminated2022-11-11Actual
Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsNCT04987229Alkermes, Inc.Phase 3Enrolling by invitation2027-09Estimated
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett SyndromeNCT04988867ACADPhase 2, Phase 3Terminated2023-05-31Actual
(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisNCT04996875COGTPhase 2Recruiting2025-09-19Actual
Study of Plozasiran (ARO-APOC3) in Adults With Mixed DyslipidemiaNCT04998201Arrowhead PharmaceuticalsPhase 2Completed2023-02-10Actual
Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled HypertensionNCT05001945MLYSPhase 2Completed2022-09-07Actual
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)NCT05002127ALX Oncology Inc.Phase 2, Phase 3Active not recruiting2024-05-24Actual
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesNCT05003986TVTXPhase 2Recruiting2027-03-12Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.